Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease

被引:18
|
作者
Mendoza, Yuly [1 ]
Cocciolillo, Sila [2 ]
Chen, Tianyan [1 ]
Margini, Cristina [2 ]
Sebastiani, Giada [1 ]
Berzigotti, Annalisa [2 ]
Murgia, Giuseppe [1 ]
机构
[1] Univ Bern, Bern Univ Hosp, Inselspital, Univ Clin Visceral Surg & Med,Dept Biomed Res, Bern, Switzerland
[2] McGill Univ, Royal Victoria Hosp, Div Gastroenterol & Hepatol, Hlth Ctr, Montreal, PQ, Canada
关键词
Cirrhosis; Ultrasound; NASH; Fibrosis; CONTROLLED ATTENUATION PARAMETER; STIFFNESS MEASUREMENT; RISK; COMPLICATIONS; PREDICTION; FIBROSIS;
D O I
10.1016/j.cgh.2020.04.018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Some patients with compensated advanced chronic liver disease (cACLD) require use of an extralarge probe for liver stiffness measurement (LSM), owing to overweight or obesity. However, the ability of noninvasive markers of portal hypertension and the controlled attenuation parameter (CAP) to determine which of these patients are at risk for decompensation has not been fully assessed. METHODS: We collected data from 272 patients with cACLD (LSM double dagger 10 kPa by XL probe; 57% with nonalcoholic steatohepatitis; mean body mass index, 33.8 6.5 kg/m2; median Child-Pugh score, 5; median LSM, 16.8 kPa; mean CAP, 318 66 dB/m) evaluated at 2 academic centers from 2015 through 2018. We collected clinical data on decompensation (ascites, portal hypertension bleeding, jaundice, hepatic encephalopathy) and severe bacterial infections; patients were followed up for a median of 17 months (interquartile range, 11-24 mo). We evaluated associations between these events and LSM, CAP, LSM*spleen size/platelet count (LSPS), and portal hypertension risk scores. RESULTS: Decompensation occurred in 12 patients and severe bacterial infections developed in 5 patients. LSM, LSPS, and the portal hypertension risk score identified patients with decompensation with area under the receiver operating characteristic curve values of 0.848 (95% CI, 0.720-0.976; P < .0001), 0.881 (95% CI, 0.798-0.954; P < .0001), and 0.890 (95% CI, 0.814-0.966; P < .0001), respectively. In multivariate Cox regression analysis, in patients with nonalcoholic steatohepatitis, LSM and CAP were associated independently with decompensation and severe bacterial infection; CAP >= 220 dB/m was associated with a reduced risk of decompensation (hazard ratio, 0.043, 95% CI, 0.004-0.476; P =.01). CONCLUSIONS: LSM, LSPS, and the portal hypertension risk score identify obese or overweight patients with cACLD who are at increased risk of decompensation and severe bacterial infection.
引用
收藏
页码:3017 / +
页数:15
相关论文
共 50 条
  • [41] Assessment of noninvasive hepatic fibrosis markers among patients with chronic HCV infection and advanced liver disease
    Maan, Raoel
    van der Meer, Adriaan J.
    Feld, Jordan J.
    Wedemeyer, Heiner
    DuFour, Jean-Francois J.
    Lammert, Frank
    Duarte-Rojo, Andres
    Manns, Michael P.
    Zeuzem, Stefan
    Hofmann, Wolf P.
    Janssen, Harry L.
    Hansen, Bettina E.
    Veldt, Bart J.
    de Knegt, Robert J.
    HEPATOLOGY, 2014, 60 : 929A - 930A
  • [42] HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease
    Wieland, Amanda
    Etzion, Ohad
    Ali, Rabab O.
    Levy, Elliot
    Kleiner, David E.
    Helmke, Steve M.
    Heller, Theo
    Everson, Gregory T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (04) : e890 - e894
  • [43] Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection
    Kablawi, Dana
    Alhinai, Alshaima
    Wong, Philip
    Deschenes, Marc
    Sebastiani, Giada
    Benmassaoud, Amine
    HIV MEDICINE, 2023, 24 (03) : 366 - 371
  • [44] Liver stiffness by transient elastography to detect portosinusoidal vascular liver disease in patients with portal hypertension
    Elkrief, Laure
    Marie, Lazareth
    Chevret, Sylvie
    Paradis, Valerie
    Rubbia-Brandt, Laura
    Durand, Francois
    Laurent, Castera
    Audrey, Payance
    Marion, Malphettes
    Plessier, Aurelie
    Chaffaut, Cendrine
    Audureau, Etienne
    Valla, Dominique
    Nahon, Pierre
    Ganne-Carrie, Nathalie
    Rautou, Pierre-Emmanuel
    JOURNAL OF HEPATOLOGY, 2020, 73 : S732 - S733
  • [45] Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
    Rodrigues, Susana G.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (01) : 110 - 112
  • [46] Comparison of coagulation parameters as prognostic markers of decompensation and liver-related death in advanced chronic liver disease
    Pallozzi, Maria
    Giuli, Lucia
    Santopaolo, Francesco
    Gasbarrini, Antonio
    De Cristofaro, Raimondo
    Pompili, Maurizio
    Ponziani, Francesca Romana
    JOURNAL OF HEPATOLOGY, 2023, 78 : S252 - S253
  • [47] Risk stratification of decompensation using liver stiffness and platelet counts in compensated advanced chronic liver disease (CHESS2102)
    Liu, Yanna
    Liu, Chuan
    Li, Jia
    Kim, Tae Hyung
    Enomoto, Hirayuki
    Qi, Xiaolong
    JOURNAL OF HEPATOLOGY, 2022, 76 (01) : 248 - 250
  • [48] Chronic liver disease and portal hypertension in children
    Anon
    Ultrasound in Medicine and Biology, 2000, 26 (SUPPL. 2):
  • [49] Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease
    Mulazzani, L.
    Sansone, V.
    Berzigotti, A.
    Stefanescu, H.
    Allegretti, G.
    Ravaioli, F.
    Marasco, G.
    Di Bonaventura, C.
    Serra, C.
    Vukotic, R.
    Bolondi, L.
    Bosch, J.
    Piscaglia, F.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 48 - 48
  • [50] Spleen stiffness measurement improves non-invasive prediction of clinically significant portal hypertension in patients with compensated advanced chronic liver disease of mixed etiology
    Manfredi, Giulia Francesca
    Strada, Angelo
    Lotto, Mattia
    Romano, Valentina
    Bonafede, Vincenzo
    Burlone, Michela
    Minisini, Rosalba
    Pirisi, Mario
    Rigamonti, Cristina
    JOURNAL OF HEPATOLOGY, 2024, 80 : S627 - S627